Respiratory Disorders Genetic Panel

Long Description:

The Respiratory Disorders Genetic Panel is a comprehensive next-generation sequencing (NGS) assay designed to detect genetic variants associated with a wide range of inherited respiratory conditions. The panel covers clinically relevant genes linked to disorders such as cystic fibrosis, primary ciliary dyskinesia, alpha-1 antitrypsin deficiency, interstitial lung disease, pulmonary fibrosis, pulmonary arterial hypertension, bronchiectasis, and other genetic respiratory conditions.

This test enables high-resolution genetic analysis to support early diagnosis, differential diagnosis, and risk assessment. It helps clinicians guide patient management, family screening, and personalized treatment strategies.

The assay is performed using high-quality NGS technology with robust bioinformatics analysis to ensure accurate variant detection and interpretation based on current clinical guidelines.